Eli Lilly has FDA approval for emergency use of the drug, and has received Ministry of Health (MOH) approval as of January 12,2021. These approvals were based on the Blaze-1 study published in print in the New England Journal of Medicine on Jan. 21, 2021( but e-published much earlier, on Oct. 28,2020- which formed the basis of early use of the drug in the US in 2020). Blaze-1 showed that BAM cuts hospitalizations by 75%.
Check out the full article right here.